GLIMECHECK M 0.5

Glimecheck M 0.5 Tablet is a combination of Glimepiride 0.5 mg and Metformin Hydrochloride, designed to provide dual-action control for Type 2 Diabetes Mellitus. This combination works by reducing glucose production in the liver (Metformin) and increasing insulin secretion from the pancreas (Glimepiride), leading to improved blood sugar regulation.

It is commonly prescribed as a first-line treatment for newly diagnosed Type 2 diabetic patients or for those not controlled on metformin alone.

Key Benefits:

• Dual mechanism improves insulin sensitivity and secretion

• Helps lower both fasting and post-meal blood sugar levels

• Reduces the risk of long-term complications from diabetes

• Low-dose Glimepiride reduces risk of hypoglycemia

• Suitable for mild to moderate Type 2 Diabetes